Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer
March 08 2023 - 8:30AM
Business Wire
Connolly comes to Aditxt with more than two
decades of experience in the health, wellness, science, and
technology space.
Aditxt, Inc., (NASDAQ: ADTX) (“Aditxt” or the “Company”), an
innovation company developing and commercializing technologies with
a focus on monitoring and modulating the immune system, is pleased
to announce Maureen Connolly has joined Aditxt as Chief Content and
Engagement Officer. Connolly is an award-winning content strategist
and audience builder with 25+ years of experience in the health,
science, wellness, technology, and chronic conditions space. She
works with product, marketing, and engineering teams to create
content platforms where businesses can engage with global audiences
while building communities that feel supported and connected.
“Maureen’s background, experience and passion couldn’t be better
fit for this role,” said Amro Albanna, co-founder, chairman, and
CEO of Aditxt. “Maureen will design and implement Aditxt’s vision
for engaging stakeholders into its mission. We look forward to her
driving and overseeing the strategy that will greatly advance our
priority of keeping our stakeholders informed and engaged.”
Connolly’s previous roles include Editor in Chief, Group Vice
President of Everyday Health, one of the world’s largest consumer
health sites. Connolly was also Editorial Director at Vertical
Health (now Remedy Health Media), where she oversaw five health
websites aimed at medical professionals and patients. She's written
and edited for the Cleveland Clinic Wellness Institute, PBS, Random
House, Harvard Common Press, Hearst, Conde Nast, and Time Inc. She
is the author of three books, the executive producer and host of
the mental health series “Boxed In: Covid-19 and Your Mental
Health,” and has been a featured guest on NPR.
“Content can’t be king unless there is meaningful engagement
around it,” said Connolly. “Aditxt believes in radically
transparent communication and engagement across the board — with
patients, shareholders, Wall Street, doctors and employees. And
because true engagement is a two-way street, disruptive innovation
will only come to life when we allow the voices of those we serve
to help shape our strategic direction.”
About Aditxt
Aditxt is an innovation company developing and commercializing
technologies focused on monitoring and modulating the immune
system. Aditxt’s immune monitoring technologies are designed to
provide a personalized immune profile. Aditxt’s immune modulating
technologies, currently preclinical, are being developed to retrain
the immune system to induce tolerance to address rejection of
transplanted organs, autoimmune diseases, and allergies.
For more information, visit the Company’s websites at
www.Aditxt.com and www.AditxtScore.com.
Forward-Looking Statements
Certain statements in this press release constitute
"forward-looking statements" within the meaning of federal
securities laws. Forward-looking statements include statements
regarding the Company's intentions, beliefs, projections, outlook,
analyses or current expectations concerning, among other things,
the Company's ongoing and planned product and business development;
the Company's intellectual property position; the Company's ability
to develop commercial functions; expectations regarding product
launch and revenue; the Company's results of operations, cash
needs, spending, financial condition, liquidity, prospects, growth
and strategies; the industry in which the Company operates; and the
trends that may affect the industry or the Company. Forward-looking
statements are not guarantees of future performance and actual
results may differ materially from those indicated by these
forward-looking statements as a result of various important
factors, as well as market and other conditions and those risks
more fully discussed in the section titled "Risk Factors" in the
Company's most recent Annual Report on Form 10-K, as well as
discussions of potential risks, uncertainties, and other important
factors in the Company's other filings with the Securities and
Exchange Commission. All such statements speak only as of the date
made, and the Company undertakes no obligation to update or revise
publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230308005224/en/
ir@aditxt.com www.aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From May 2024 to Jun 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Jun 2023 to Jun 2024